A one‐stop approach to diagnosing hereditary colorectal cancer in the Chinese population
Journal of Gastroenterology and Hepatology · 2023
DOI: 10.1111/jgh.16319 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2023. Verfasst von Cong Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: Adenomatous Polyposis Coli, Colorectal Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanghai Municipal Hospital Development Center, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Background and Aim The current procedure for identifying hereditary colorectal cancer (HCRC) is time consuming in clinical practice. This study aimed to develop a time‐saving approach to diagnosing HCRC.
Methods
A total of 100 suspected HCRC patients were prospectively enrolled (cohort 1) and 116 colorectal cancer patients with DNA mismatch repair‐deficient were retrospectively included (cohort 2). Next‐generation sequencing (NGS) tests were performed on tumors and matched white blood cells (WBCs) or normal tissues. Using the conventional method upon WBC/normal tissue‐based NGS data as a reference, the performance of the ColonCore method using tumor‐only‐based NGS data in predicting germline variants was explored in cohort 1 and validated in cohort 2.
Results
In cohort 1, the ColonCore method diagnosed 17 Lynch syndrome (LS) and 14 familial adenomatous polyposis (FAP); and by the conventional method, the cases were 16 and 10, respectively. The ColonCore method showed sensitivities of 100% in diagnosing LS (positive predictive value [PPV] 94.1%) and FAP (PPV 71.4%). Moreover, two of seven patients with multiple adenomas/polyps who did not meet existing clinical criteria for HCRC were predicted to harbor germline variants in APC and MUTYH . Additionally, the sensitivity of the ColonCore method in identifying LS patients from cohort 2 reached 85.7% with a PPV of 85.7%.
Conclusion
The ColonCore method might be an acceptable tool for predicting germline variants associated with HCRC. Our work indicates the essentiality of NGS tests in CRC patients for precision diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
ORCID-Profile: Fangqi Liu
Förderung
- Shanghai Municipal Hospital Development Center
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Li, C., Song, W., Xu, Y., Guo, T., Zhou, X., Liu, F., & Xu, Y. (2023). A one‐stop approach to diagnosing hereditary colorectal cancer in the Chinese population. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16319
Vancouver
Li C, Song W, Xu Y, Guo T, Zhou X, Liu F, et al. A one‐stop approach to diagnosing hereditary colorectal cancer in the Chinese population. Journal of Gastroenterology and Hepatology. 2023. doi:10.1111/jgh.16319
BibTeX
@article{Li2023,
author = {Li, Cong and Song, Wang and Xu, Yun and Guo, Tianan and Zhou, Xiaoyan and Liu, Fangqi and Xu, Ye},
title = {A one‐stop approach to diagnosing hereditary colorectal cancer in the Chinese population},
journal = {Journal of Gastroenterology and Hepatology},
year = {2023},
doi = {10.1111/jgh.16319}
}
EUVIMED